Zoetis (ZTS) Tax Provisions (2012 - 2026)
Zoetis (ZTS) posted quarterly Tax Provisions of $157.0 million for Q1 2026, down 8.19% year-over-year from $171.0 million in Q1 2025, and down 0.63% quarter-over-quarter from $158.0 million in Q4 2025.
Zoetis (ZTS) Tax Provisions (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Tax Provisions for 15 consecutive years, with $157.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions fell 8.19% year-over-year to $157.0 million; the TTM figure through Mar 2026 stood at $665.0 million (up 0.76% YoY), while the FY2025 annual figure was $687.0 million, up 7.85% from the prior year.
- Tax Provisions declined to $157.0 million in Q1 2026 per ZTS's latest filing, from $158.0 million in the prior quarter.
- Across five years, Tax Provisions topped out at $202.0 million in Q2 2023 and bottomed at $121.0 million in Q3 2023.
- Historically, Tax Provisions has averaged $153.8 million across 5 years, with a median of $151.0 million in 2024.
- On a YoY basis, Tax Provisions climbed as much as 50.41% in 2024 and fell as far as 22.77% in 2024.
- Zoetis' Tax Provisions stood at $132.0 million in 2022, then decreased by 3.79% to $127.0 million in 2023, then advanced by 18.9% to $151.0 million in 2024, then gained by 4.64% to $158.0 million in 2025, then retreated by 0.63% to $157.0 million in 2026.
- Business Quant data shows ZTS's Tax Provisions at $157.0 million in Q1 2026, $158.0 million in Q4 2025, and $166.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | -2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 175.00 Mn |
| Mar 31, 2026 | 157.00 Mn |
| Dec 31, 2025 | 158.00 Mn |
| Sep 30, 2025 | 166.00 Mn |
| Jun 30, 2025 | 184.00 Mn |
| Mar 31, 2025 | 171.00 Mn |
| Dec 31, 2024 | 151.00 Mn |
| Sep 30, 2024 | 182.00 Mn |
| Jun 30, 2024 | 156.00 Mn |
| Mar 31, 2024 | 148.00 Mn |
| Dec 31, 2023 | 127.00 Mn |
| Sep 30, 2023 | 121.00 Mn |
| Jun 30, 2023 | 202.00 Mn |
| Mar 31, 2023 | 146.00 Mn |
| Dec 31, 2022 | 132.00 Mn |
| Sep 30, 2022 | 139.00 Mn |
| Jun 30, 2022 | 141.00 Mn |
| Mar 31, 2022 | 133.00 Mn |
| Dec 31, 2021 | 93.00 Mn |
| Sep 30, 2021 | 107.00 Mn |